Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Donepezil Augmentation for Cognitive Deficits in Schizophrenia
NCT00206947Phase 2Terminated
- Start
- Dec 2002
- Primary completion
- Jan 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of donepezil in schizophrenia. Started Dec 2002; status: terminated.
02
Drugs
donepezil
03
Conditions
schizophrenia
Beyond the preview
Go deeper on NCT00206947.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00206947.